Skip to main content
Clinical Trials/TCTR20210314002
TCTR20210314002
Enrolling By Invitation
Phase 1

Sentinel lymph node mapping and ultrastaging in patients with early stage cervical cancer

/A0 sites23 target enrollmentMarch 14, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Early stage cervical cancer (stage IA2-IIA)
Sponsor
/A
Enrollment
23
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 14, 2021
End Date
February 10, 2022
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\.Early stage cervical cancer (stage IA2\-IIA) patients, who detect cervical cancer lesion size less than 4 cm underwent surgery in Siriraj hospital.
  • 2\.The surgical process are include open laparotomy and laparoscopic surgery.
  • 3\.No previous treatment (radiotherapy, chemotherapy)
  • 4\.No underwent pelvic and paraaortic Lymph node Surgery.
  • 5\.No contraindication for indocyanine green (iodine sensitivity , hepatic impairment)

Exclusion Criteria

  • 1\.Patient can't be able to underwent SLN surgery., 2\. pregnancy women

Outcomes

Primary Outcomes

Not specified

Similar Trials